![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Monday, September 04, 2023 12:16:32 AM
It can used as an oral pill for Covid (India trial is in the last part of the phase III trial already) and the US FDA IND is the first and only viable Long Haul Covid trial.
The India trial data is saying it will work for long haul covid, because it works for covid.
I called the Moderna buy in March 2020, before most people new Covid was going to be a problem based on the science.
Now here is the catch. Covid is so wide spread now, and mutates so fast, and it is jumping from Humans to deer, and Mink and back to humans, with massive new mutations they will never get rid of it with vaccines. And they can not make and test and distribute vaccines fast enough.
BIXT's antiviral works differently that the vaccines.
The Vaccines do not block cell infection.
The BIXT non toxic antiviral drug blocks the Covid / corona spikes so they can not infect human cells.
So no matter how many mutations the Covid comes up with the BIXT will still block off the spikes and their ability to attach to and infect cells.
So Infected people, can take the pill or IV and be back at work on day 4.
The new waves, Covid mutations that evade the vaccines and natural immunity world wide will keep coming, so demand for the BIXT drug will be steady world wide.
The drug can also work on Other corona viruses like the flue. This is going to be the best thing since sliced bread.
![Bullish](/static/images/ih2-bull.png)
Recent BIXT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:43:10 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 03:09:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 01:05:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 01:02:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 10:34:21 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 10/02/2023 03:36:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/26/2023 09:04:03 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 09/21/2023 02:53:48 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/19/2023 05:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 07:09:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 07:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 06:45:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 01:15:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2023 06:07:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/07/2023 01:23:13 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM